“Abbott Labs to Pay $1.5 Billion to Resolve Criminal and Civil Investigations of Off-label Promotion of Depakote: Company Maintained Specialized Sales Force to Market Drug for Off Label Purposes; Targeted Elderly Dementia Patients in Nursing Homes” (May 7, 2012). At the bottom of the news release, there ar links to various topical court documents (.pdf format).
May 8, 2012
No Comments
No comments yet.
RSS feed for comments on this post.
Sorry, the comment form is closed at this time.
